AU2013396752B2 - Method for manufacturing a shaped cross-linked hyaluronic acid product - Google Patents

Method for manufacturing a shaped cross-linked hyaluronic acid product Download PDF

Info

Publication number
AU2013396752B2
AU2013396752B2 AU2013396752A AU2013396752A AU2013396752B2 AU 2013396752 B2 AU2013396752 B2 AU 2013396752B2 AU 2013396752 A AU2013396752 A AU 2013396752A AU 2013396752 A AU2013396752 A AU 2013396752A AU 2013396752 B2 AU2013396752 B2 AU 2013396752B2
Authority
AU
Australia
Prior art keywords
cross
hyaluronic acid
linked
gel
linking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2013396752A
Other languages
English (en)
Other versions
AU2013396752A1 (en
Inventor
Anne HELANDER KENNE
Morgan KARLSSON
Ake Ohrlund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma SA
Original Assignee
Galderma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma SA filed Critical Galderma SA
Publication of AU2013396752A1 publication Critical patent/AU2013396752A1/en
Application granted granted Critical
Publication of AU2013396752B2 publication Critical patent/AU2013396752B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
    • D01F9/00—Artificial filaments or the like of other substances; Manufacture thereof; Apparatus specially adapted for the manufacture of carbon filaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Textile Engineering (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Inorganic Chemistry (AREA)
AU2013396752A 2013-06-28 2013-06-28 Method for manufacturing a shaped cross-linked hyaluronic acid product Ceased AU2013396752B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2013/063716 WO2014206500A1 (en) 2013-06-28 2013-06-28 Method for manufacturing a shaped cross-linked hyaluronic acid product

Publications (2)

Publication Number Publication Date
AU2013396752A1 AU2013396752A1 (en) 2016-02-18
AU2013396752B2 true AU2013396752B2 (en) 2018-11-08

Family

ID=48703545

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013396752A Ceased AU2013396752B2 (en) 2013-06-28 2013-06-28 Method for manufacturing a shaped cross-linked hyaluronic acid product

Country Status (11)

Country Link
US (4) US10077321B2 (OSRAM)
EP (2) EP3013865B1 (OSRAM)
JP (1) JP6434003B2 (OSRAM)
KR (1) KR102048395B1 (OSRAM)
CN (2) CN109734825B (OSRAM)
AU (1) AU2013396752B2 (OSRAM)
BR (1) BR112015031589A2 (OSRAM)
CA (1) CA2916119A1 (OSRAM)
MX (1) MX369409B (OSRAM)
RU (1) RU2640865C2 (OSRAM)
WO (1) WO2014206500A1 (OSRAM)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101831948B1 (ko) * 2015-02-13 2018-02-23 주식회사 엔도더마 가교된 히알루론산 하이드로젤을 이용한 마이크로구조체 및 이의 제조방법
US11021580B2 (en) 2015-07-27 2021-06-01 Galderma Holding SA Process for efficient cross-linking of hyaluronic acid
KR101709608B1 (ko) * 2015-09-03 2017-03-09 (주)진우바이오 용융 방사에 의한 히알루론산염 파이버의 제조방법 및 이로부터 제조된 히알루론산염 파이버
CA2999044A1 (en) 2015-09-18 2017-03-23 Arkema Inc. Polyol pre-mixes having improved shelf life
KR20170090965A (ko) * 2016-01-29 2017-08-08 한미약품 주식회사 복합 히알루론산 가교물 및 그 제조방법
EP3528858B1 (en) * 2016-10-18 2020-10-21 Aarhus Universitet Printed hyaluronic acid scaffolds
EP3562470A1 (en) 2016-12-29 2019-11-06 Nestlé Skin Health SA Composition comprising a crosslinked hyaluronic acid (ha) in combination with a low-molecular ha and/or an agent stimulating endogenous ha synthesis
WO2018122342A1 (en) * 2016-12-29 2018-07-05 Nestlé Skin Health Sa Micro- or nanoparticular multilamellar vesicles, compositions comprising the same and method for their use in skin care
EP3562469A1 (en) 2016-12-29 2019-11-06 Nestlé Skin Health SA Micro- or nanoparticular vesicles comprising crosslinked hyaluronic acid, compositions comprising the same and method for their use in skin care
IL269506B2 (en) 2017-03-22 2024-04-01 Genentech Inc Hydrogel cross-linked hyaluronic acid prodrug compositions and methods
WO2019073364A1 (en) * 2017-10-12 2019-04-18 Solyplus Berlin Gmbh CROSSLINKING BIOPOLYMERS IN A SEMI-SOLID STATE
JP7374133B2 (ja) * 2018-06-15 2023-11-06 クロマ－ファーマ ゲゼルシャフト エム．ベー．ハー． 安定化されたヒアルロン酸
WO2020194294A1 (en) * 2019-03-24 2020-10-01 Luminera-Derm Ltd. Injectable homogeneous gels comprising multiple forms of hyaluronic acid and methods for manufacturing thereof
CA3135919A1 (en) * 2019-04-19 2020-10-22 Jointherapeutics Srl Crosslinked polymer of functionalized hyaluronic acid and its use in the treatment of inflammatory states
EP3797800A1 (en) * 2019-05-02 2021-03-31 Institut National De La Sante Et De La Recherche Medicale - Inserm Hyaluronic acid hydrogels with prolonged antimicrobial activity
WO2020234167A1 (en) * 2019-05-17 2020-11-26 ETH Zürich Printable hydrogel, method for generating a printable hydrogel, lyophilizate, printed product and 3d printing method
CN112147029A (zh) * 2019-06-28 2020-12-29 杭州协合医疗用品有限公司 一种交联透明质酸钠凝胶溶胀度的测定方法
EP3995530B1 (en) * 2019-09-27 2025-05-28 LG Chem, Ltd. A method of preparing polymer microparticles, polymer microparticles, medical composition, cosmetic composition, medical articles, and cosmetic articles using the same
KR102173790B1 (ko) 2020-02-26 2020-11-03 (주) 제이피케어즈 가교 히알루론산을 이용한 약물 전달 조성물 및 이의 제조방법
EP4171671A4 (en) * 2020-06-24 2024-07-24 Anika Therapeutics, Inc. COMPOSITE MEDICAL TEXTILE WITH NON-ABSORBABLE FIBERS AND BIOABSORBABLE FIBERS BASED ON HYALURONANE
JP7346551B2 (ja) * 2020-11-26 2023-09-19 ジンウ バイオ カンパニー リミテッド ヒアルロン酸塩ファイバーおよびその製造方法
KR102527095B1 (ko) 2020-12-18 2023-04-28 충남대학교산학협력단 가교 처리된 히알루론산 조성물의 가교율 측정방법
CN113045779B (zh) * 2021-03-22 2022-09-02 华熙生物科技股份有限公司 一种交联透明质酸凝胶粗品及其制备方法
EP4415771A4 (en) * 2021-10-15 2025-09-10 Prohibix Llc CROSS-LINKED HYALURONIC ACID PRECIPITATES
CN114404355B (zh) * 2021-12-28 2024-05-24 常州药物研究所有限公司 透明质酸钠凝胶及其制备方法、应用
WO2023148619A1 (en) 2022-02-01 2023-08-10 Galderma Holding SA Methods of producing crosslinked hyaluronic acid hydrogels
CN114894789B (zh) * 2022-06-28 2025-08-15 华熙生物科技股份有限公司 一种透明质酸类物质指示剂组合物及其在快速检测透明质酸类物质中的应用
TWI840941B (zh) * 2022-09-06 2024-05-01 科妍生物科技股份有限公司 製造自體交聯透明質酸凝膠之方法及其產物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070004159A (ko) * 2005-07-04 2007-01-09 주식회사 엘지생명과학 히알루론산 가교물의 제조방법
US20070066816A1 (en) * 2002-12-31 2007-03-22 Industrial Technology Research Institute Method for producing double-crosslinked hyaluronate material
EP2199308A1 (en) * 2007-09-28 2010-06-23 Shiseido Company, Ltd. Swellable crosslinked hyaluronic acid powder and method for producing the same

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605691A (en) * 1984-12-06 1986-08-12 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
AU619760B2 (en) * 1987-12-10 1992-02-06 Genzyme Biosurgery Corporation Hylan preparation and method of recovery thereof from animal tissues
JPH01197501A (ja) 1988-02-02 1989-08-09 Mitsubishi Acetate Co Ltd 精製サイリウムガムの製造方法
US5827937A (en) * 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
GB9902412D0 (en) * 1999-02-03 1999-03-24 Fermentech Med Ltd Process
TW574301B (en) * 2001-05-02 2004-02-01 Ind Tech Res Inst Manufacturing method of epoxide crosslinked polysaccharides matrix
DE10223310A1 (de) * 2002-05-24 2003-12-11 Biotronik Mess & Therapieg Verfahren zum Beschichten von Implantaten mit einer Polysaccharid-Lage
US7323425B2 (en) * 2004-08-27 2008-01-29 Stony Brook Technology And Applied Research Crosslinking of hyaluronan solutions and nanofiberous membranes made therefrom
US20060105022A1 (en) 2004-11-15 2006-05-18 Shiseido Co., Ltd. Process for preparing crosslinked hyaluronic acid gel
JP4875988B2 (ja) * 2004-11-15 2012-02-15 株式会社 資生堂 架橋ヒアルロン酸ゲルの製造方法
FR2908415B1 (fr) * 2006-11-10 2009-01-23 Abr Dev Sarl Acide hyaluronique reticule et son procede de preparation
KR20080062092A (ko) * 2006-12-29 2008-07-03 주식회사 핸슨바이오텍 세포전달체로서의 히알루론산 유도체 및 이의 제조 방법
CN101313915B (zh) * 2007-05-30 2011-04-20 北京泰克美科技有限公司 透明质酸及其盐、交联透明质酸及其盐在制备治疗或预防海泡伤药物中的应用
US8318695B2 (en) * 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
FR2920786B1 (fr) * 2007-09-07 2010-09-10 Univ Claude Bernard Lyon Fibres creuses, notamment multi membranaires, leur procede de preparation par filage et dispositif pour la mise en oeuvre dudit procede
ITMI20072416A1 (it) * 2007-12-21 2009-06-22 Sigea Srl Derivati polisaccaridici dell'acido lipoico, loro preparazione ed uso come dermocosmetici e presidi medicali
CA2757557C (en) 2009-04-02 2017-06-27 Allergan, Inc. Hair-like shaped hydrogels for soft tissue augmentation
AU2010276574B2 (en) * 2009-07-30 2015-08-20 Carbylan Therapeutics, Inc. Modified hyaluronic acid polymer compositions and related methods
US20130274222A1 (en) * 2010-10-20 2013-10-17 Tautona Group Lp Threads of cross-linked hyaluronic acid and methods of preparation and use thereof
CZ302994B6 (cs) * 2010-12-31 2012-02-08 Cpn S.R.O. Hyaluronová vlákna, zpusob jejich prípravy a použití
CN102552974A (zh) * 2012-02-17 2012-07-11 上海白衣缘生物工程有限公司 皮肤注射填充用凝胶组合物及其制备
CN102660040B (zh) * 2012-05-03 2014-03-12 杭州协合医疗用品有限公司 一种透明质酸钠凝胶的制备方法
CN102731801B (zh) * 2012-07-13 2013-12-25 常州药物研究所有限公司 外科整形用交联透明质酸钠凝胶及其制备方法
CN102863631B (zh) * 2012-09-29 2013-11-13 杭州嘉伟生物制品有限公司 外科整形用组织填充剂交联透明质酸钠凝胶及其制备方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070066816A1 (en) * 2002-12-31 2007-03-22 Industrial Technology Research Institute Method for producing double-crosslinked hyaluronate material
KR20070004159A (ko) * 2005-07-04 2007-01-09 주식회사 엘지생명과학 히알루론산 가교물의 제조방법
EP2199308A1 (en) * 2007-09-28 2010-06-23 Shiseido Company, Ltd. Swellable crosslinked hyaluronic acid powder and method for producing the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LAURENT T C ET AL, "CROSS-LINKED GELS OF HYALURONIC ACID", ACTA CHEMICA SCANDINAVICA, MUNKSGAARD, COPENHAGEN, DK, (1964-01-01), vol. 18, no. 1, ISSN 0904-213X, page 274/275 *
TOMIHATA K ET AL, "CROSSLINKING OF HYALURONIC ACID WITH WATER-SOLUBLE CARBODIIMIDE", JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, WILEY, NEW YORK, NY, US, (1997-11-01), vol. 37, no. 2, (1997), pages 243 - 251 *

Also Published As

Publication number Publication date
CA2916119A1 (en) 2014-12-31
JP6434003B2 (ja) 2018-12-05
CN105473622A (zh) 2016-04-06
US10982016B2 (en) 2021-04-20
HK1224314A1 (en) 2017-08-18
AU2013396752A1 (en) 2016-02-18
WO2014206500A1 (en) 2014-12-31
CN109734825B (zh) 2022-01-28
BR112015031589A2 (pt) 2017-07-25
MX2015017526A (es) 2016-08-05
EP3617236A1 (en) 2020-03-04
US10077321B2 (en) 2018-09-18
KR20160027095A (ko) 2016-03-09
US20200247913A1 (en) 2020-08-06
CN105473622B (zh) 2019-01-29
KR102048395B1 (ko) 2019-11-25
US20160145357A1 (en) 2016-05-26
MX369409B (es) 2019-11-07
US11702484B2 (en) 2023-07-18
EP3013865A1 (en) 2016-05-04
RU2016101734A (ru) 2017-08-02
EP3013865B1 (en) 2019-10-23
RU2640865C2 (ru) 2018-01-12
JP2016524016A (ja) 2016-08-12
US20180362670A1 (en) 2018-12-20
CN109734825A (zh) 2019-05-10
EP3617236B1 (en) 2024-07-31
US20210214468A1 (en) 2021-07-15

Similar Documents

Publication Publication Date Title
US11702484B2 (en) Method for manufacturing a shaped cross-linked hyaluronic acid product
AU2014301493B2 (en) A process for preparing a cross-linked hyaluronic acid product
US12454602B2 (en) Process for efficient cross-linking of hyaluronic acid
HK1224314B (en) Method for manufacturing a shaped cross-linked hyaluronic acid product
EP3013866B1 (en) A process for preparing a cross-linked hyaluronic acid product

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired